ALGOMIRA partners with biotech and pharmaceutical organizations to accelerate drug discovery through the integration of New Approach Methodologies (NAMs), AI/ML-driven precision medicine, and deep translational science.
Our strategy and analytics practice spans the full discovery arc — from EHR-derived disease mechanism mapping and precision genomics, through patient-derived organoid and organ-on-chip model generation, to machine learning frameworks for multiomics data integration and targeted therapeutic screening in human tissue systems. We combine strategic advisory with hands-on scientific execution, designing for both biological rigor and the FDA's evolving NAMs regulatory roadmap from day one.
Our mission: translating the full complexity of human disease — from patient data to mechanism to molecule to safety — into breakthrough therapeutic decisions that are faster, safer, and built for the next generation of drug development.

ALGOMIRA

Org chart

Teams

Offices

ALGOMIRA

Org chart

Teams

Offices

Related companies